COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson's disease

被引：0
|
作者：
Akhmadeeva, G.
Khidiyatova, I.
Gilyazova, I.
Umutbaev, S.
Kachemaeva, O.
Baitimerov, A.
Galimova, R.
Magzhanov, R.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1278
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [21] Risperidone and suppression of levodopa-induced dyskinesia in Parkinson's disease
    Parsa, MA
    Greenaway, HM
    Mangat, TS
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 137S - 137S
  • [22] Parkinson's disease: Levodopa-induced dyskinesia and signal transduction
    Santini, Emanuela
    Valjent, Emmanuel
    Fisone, Gilberto
    FEBS JOURNAL, 2008, 275 (07) : 1392 - 1399
  • [23] Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease
    Carpentier, AF
    Bonnet, AM
    Vidailhet, M
    Agid, Y
    NEUROLOGY, 1996, 46 (06) : 1548 - 1551
  • [24] Levodopa-induced dyskinesia in Parkinson's disease: Sleep matters
    Amato, N.
    Manconi, M.
    Moller, J. C.
    Sarasso, S.
    Stanzione, P.
    Stadler, C.
    Kaelin-Lang, A.
    Galati, S.
    MOVEMENT DISORDERS, 2018, 33 : S774 - S777
  • [25] Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Schaeffer, Eva
    Pilotto, Andrea
    Berg, Daniela
    CNS DRUGS, 2014, 28 (12) : 1155 - 1184
  • [26] Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease
    Eva Schaeffer
    Andrea Pilotto
    Daniela Berg
    CNS Drugs, 2014, 28 : 1155 - 1184
  • [27] Risk factors for levodopa-induced dyskinesia in Serbian Parkinson's disease patients
    Markovic, V.
    Djuric, G.
    Pekmezovic, T.
    Kostic, V.
    Svetel, M.
    MOVEMENT DISORDERS, 2013, 28 : S317 - S317
  • [28] The role of genetic factors in levodopa-induced dyskinesias development in Russian patients with Parkinson's disease: A pilot study
    Akhmadeeva, G.
    Khidiyatova, I.
    Gilyazova, I.
    Baitimerov, A.
    Magzhanov, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [29] Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia
    Nakajima, Asuka
    Iwamuro, Hirokazu
    Tokugawa, Joji
    Odo, Masahiko
    Shimo, Yasushi
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (02) : 322 - 323
  • [30] The role of apolipoprotein E polymorphisms in the development of levodopa-induced dyskinesia in Parkinson's disease
    Molchadski, I.
    Hassin-Baer, S.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S119 - S119
12345